These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26741564)

  • 1. Cytotoxic Effects of Phosphonate-Functionalized Mesoporous Silica Nanoparticles.
    Menon N; Leong DT
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):2416-22. PubMed ID: 26741564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J; Du X; Zheng N; Xu L; Xu J; Li S
    Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
    He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
    Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
    Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartic acid functionalized PEGylated MSN@GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery.
    Rahmatolahzadeh R; Hamadanian M; Ma'mani L; Shafiee A
    Adv Med Sci; 2018 Sep; 63(2):257-264. PubMed ID: 29486375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization.
    Nairi V; Magnolia S; Piludu M; Nieddu M; Caria CA; Sogos V; Vallet-Regì M; Monduzzi M; Salis A
    Colloids Surf B Biointerfaces; 2018 Aug; 168():50-59. PubMed ID: 29456044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Mesoporous Silica Nanoparticles Based on Charge-Reversal Plug-Gate Nanovalves and Acid-Decomposable ZnO Quantum Dots for Intracellular Drug Delivery.
    Zhang J; Wu D; Li MF; Feng J
    ACS Appl Mater Interfaces; 2015 Dec; 7(48):26666-73. PubMed ID: 26553405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
    Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
    Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles for efficient rivastigmine hydrogen tartrate delivery into SY5Y cells.
    Karimzadeh M; Rashidi L; Ganji F
    Drug Dev Ind Pharm; 2017 Apr; 43(4):628-636. PubMed ID: 28043167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionic and thermo-switchable polymer-masked mesoporous silica drug-nanocarrier: High drug loading capacity at 10°C and fast drug release completion at 40°C.
    Eltohamy M; Seo JW; Hwang JY; Jang WC; Kim HW; Shin US
    Colloids Surf B Biointerfaces; 2016 Aug; 144():229-237. PubMed ID: 27092438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles.
    Xiong L; Du X; Kleitz F; Qiao SZ
    Small; 2015 Nov; 11(44):5919-26. PubMed ID: 26426251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
    Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
    Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
    Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
    J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.